Vyvanse 30MG cap 100S
Ended Awarded
- Contract number
- SPE2DR26FBBCP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,585
Award facts
- Contract value 100% obligated
- $14,585.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $14,585.17 delivery order to Amerisourcebergen Drug Corp on June 8, 2026, for 100 Vyvanse 30mg capsules. The order was placed under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract, which supports worldwide military healthcare supply across multiple therapeutic domains.
Place of performance is Conshohocken, PA. Ultimate completion date is June 9, 2026. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FBBCP?
SPE2DR26FBBCP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 8, 2026.
How much is contract SPE2DR26FBBCP worth?
The government has obligated $14,585 on SPE2DR26FBBCP.
Is contract SPE2DR26FBBCP an order under another contract?
Yes. SPE2DR26FBBCP is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBBCP competed?
The extent of competition for SPE2DR26FBBCP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award